Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Glucose sensing module - is it time to integrate it into real-time perioperative monitoring? An observational pilot study with subcutaneous sensors

I. Poljakova, E. Elsikova, R. Chlup, S. Kalabus, P. Hasala, J. Zapletalova

. 2013 ; 157 (4) : 346-357. [pub] 20130625

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15026687

AIMS: To explore the feasibility of subcutaneous continuous glucose monitoring (CGM) in perioperative settings and to evaluate the perioperative development of glycaemia in persons with diabetes mellitus or impaired glucose tolerance by means of CGM. METHODS: Monitoring by means of Guardian REAL-Time CGMS (Medtronic, Nortridge, USA) in 20 perioperative periods. Sensor was inserted on the day before surgery and continued for 3 days with some exceptions. RESULTS: Full implementation of the method was successful in the intensive care unit setting only. No electromagnetic interference and no side effects were found. The Wilcoxon signed-rank test revealed no significant difference between sensor and laboratory analyser values. Pearson's correlation coefficients of the values obtained by sensor and the Wellion Linus glucometer were 0.875 for the whole perioperative period, 0.866 for the intraoperative period and 0.903 for the first perioperative day. A decline in sensor accuracy on the 6(th) day was registered in one case. 16 monitored cases (80%) did not meet the criteria for safe plasma glucose range. Hypoglycaemia was found in 4 (20%) cases. There was an association between grade of the perioperative dysglycaemia and need for reoperation within the next 3 months. The most frequent perioperative glycaemic patterns are demonstrated. CONCLUSION: Subcutaneous CGM is safe offering detailed insight into glucose homeostasis in the dynamic perioperative period. Laboratory confirmation of sensor plasma glucose concentration by approved laboratory analyser is still necessary. The potentional benefits of maintaining patients within a safe glucose range should be comfirmed by future studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15026687
003      
CZ-PrNML
005      
20150818085844.0
007      
ta
008      
150811s2013 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2013.049 $2 doi
035    __
$a (PubMed)23887609
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Poljaková, Iveta $u Department of Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 _AN052417
245    10
$a Glucose sensing module - is it time to integrate it into real-time perioperative monitoring? An observational pilot study with subcutaneous sensors / $c I. Poljakova, E. Elsikova, R. Chlup, S. Kalabus, P. Hasala, J. Zapletalova
520    9_
$a AIMS: To explore the feasibility of subcutaneous continuous glucose monitoring (CGM) in perioperative settings and to evaluate the perioperative development of glycaemia in persons with diabetes mellitus or impaired glucose tolerance by means of CGM. METHODS: Monitoring by means of Guardian REAL-Time CGMS (Medtronic, Nortridge, USA) in 20 perioperative periods. Sensor was inserted on the day before surgery and continued for 3 days with some exceptions. RESULTS: Full implementation of the method was successful in the intensive care unit setting only. No electromagnetic interference and no side effects were found. The Wilcoxon signed-rank test revealed no significant difference between sensor and laboratory analyser values. Pearson's correlation coefficients of the values obtained by sensor and the Wellion Linus glucometer were 0.875 for the whole perioperative period, 0.866 for the intraoperative period and 0.903 for the first perioperative day. A decline in sensor accuracy on the 6(th) day was registered in one case. 16 monitored cases (80%) did not meet the criteria for safe plasma glucose range. Hypoglycaemia was found in 4 (20%) cases. There was an association between grade of the perioperative dysglycaemia and need for reoperation within the next 3 months. The most frequent perioperative glycaemic patterns are demonstrated. CONCLUSION: Subcutaneous CGM is safe offering detailed insight into glucose homeostasis in the dynamic perioperative period. Laboratory confirmation of sensor plasma glucose concentration by approved laboratory analyser is still necessary. The potentional benefits of maintaining patients within a safe glucose range should be comfirmed by future studies.
650    _2
$a senioři $7 D000368
650    _2
$a biochemická analýza krve $x přístrojové vybavení $7 D001774
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a počítačové systémy $7 D003199
650    _2
$a studie proveditelnosti $7 D005240
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a perioperační péče $7 D019990
650    _2
$a pilotní projekty $7 D010865
650    12
$a protézy a implantáty $7 D019736
650    _2
$a subkutánní tkáň $7 D040521
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Elšíková, Eva $7 xx0244971 $u Department of Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
700    1_
$a Chlup, Rudolf, $d 1947- $7 jn20001031001 $u Department of Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic; Department of Internal Medicine II - Gastroenterology and Hepatology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc
700    1_
$a Kalabus, Stanislav $7 _AN065014 $u Department of Surgery, Prerov Regional Hospital, Central Moravia Region Inc, Prerov
700    1_
$a Hasala, Petr $7 xx0275989 $u Department of Surgery, Prerov Regional Hospital, Central Moravia Region Inc, Prerov
700    1_
$a Zapletalová, Jana $7 xx0111614 $u Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 157, č. 4 (2013), s. 346-357
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20150811 $b ABA008
991    __
$a 20150812142225 $b ABA008
999    __
$a ok $b bmc $g 1087897 $s 909723
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 157 $c 4 $d 346-357 $e 20130625 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20150811
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace